ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,116.17
      0.00%
      US Tech 100
      17,244.00
      -0.38%
      Dow Jones
      38,386.09
      0.00%
      Brent Oil
      87.145
      -0.16%
      Bitcoin
      61,148.90
      -4.21%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Alvontech (ALVO)

      7. Alvontech (ALVO) News

      ALVO Alvontech

      14.22
      0.00 (0.00%)
      Pre Market
      Last Updated: 08:45:01
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Alvontech ALVO NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 14.22 08:45:01
      Open Price Low Price High Price Close Price Prev Close
      14.22
      more quote information »

      Recent News

      Date Time Source Heading
      4/30/20248:53IHNWFeaturedCannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia
      4/30/202404:00GLOBEU.S. Commercialization Agreement with Quallent to Drive..
      4/24/202404:00GLOBEAlvotech Announces Topline Results from a Confirmatory..
      4/19/202406:10GLOBEAlvotech signs U.S. agreement to expand access for newly..
      4/16/202417:43BWAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
      4/16/202417:30GLOBEAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
      4/03/202407:41GLOBEAlvotech Hosts Audio Call for Investors at 8:15 am EDT on..
      3/22/202416:15GLOBEAlvotech Announces Increase in Number of Own Shares
      3/20/202416:15GLOBEAlvotech Reports Financial Results for Full Year 2023 and..
      3/20/202407:17IHMARKETNEWSU.S. Index Futures Trade Sideways Amid Anticipation of Fed’s..
      3/05/202416:00GLOBEAlvotech Announces Webcast of Full Year 2023 Financial..
      2/29/202416:05GLOBEAlvotech Appoints Interim Chief Quality Officer
      2/26/202404:25GLOBEAlvotech Accepts Offer for the Sale of Shares for a value of..
      2/23/202420:15GLOBEAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
      2/23/202420:15BWAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
      2/15/202406:30GLOBEAlvotech Announces Expected Global Market Entry Dates for..
      1/29/202404:00GLOBEAlvotech Announces Positive Top-Line Results from a..
      1/19/202412:31DJNAlvotech Shares Climb After FDA Concludes Facility..
      1/19/202411:30GLOBEAlvotech Provides Update on Status of Biologics License..
      1/10/202403:30GLOBESTADA and Alvotech secure approval for Uzpruvo, Europe’s..
      1/03/202403:30GLOBEAlvotech Clinical Study Results Demonstrate Therapeutic..
      11/29/202304:00GLOBEAlvotech Announces Positive Top-Line Results from a..
      11/28/202316:15GLOBEAlvotech Reports Financial Results for First Nine Months of..
      11/21/202308:00GLOBEAlvotech to Report Financial Results for the First Nine..
      11/14/202307:00GLOBEAlvotech and JAMP Pharma Announce Receipt of Marketing..
      11/10/202309:30GLOBESTADA and Alvotech receive positive CHMP opinion for..
      11/07/202308:00GLOBEAlvotech to Present at the Jefferies 2023 London Healthcare..
      10/12/202304:00GLOBEAlvotech Provides Update on Status of U.S. Biologics License..
      10/03/202308:29BWKashiv BioSciences Enters into Exclusive Licensing Agreement..
      10/03/202305:00GLOBEAlvotech Enters into Exclusive Licensing Agreement with..
      9/25/202304:00GLOBEAlvotech Announces Approval in Japan of AVT04 (ustekinumab),..
      9/20/202304:30GLOBEAlvotech Provides U.S. Regulatory Update on AVT02, a..
      9/05/202309:30GLOBEAlvotech Announces Changes to the Leadership Team
      8/30/202316:15GLOBEAlvotech Reports Financial Results for First Six Months of..
      8/29/202305:00GLOBEAlvotech and Bioventure Announce Approval of AVT02..
      8/22/202309:15GLOBEAlvotech to Report Financial Results for the First Half of..
      7/31/202304:00GLOBEAlvotech Completes $100 Million Convertible Bond Private..
      7/24/202304:00GLOBETeva Pharmaceuticals and Alvotech Provide Update on..
      7/03/202309:37DJNAlvotech Shares Rebound 20% After FDA Letter Selloff
      6/28/202320:03DJNAlvotech Gets FDA Letter, Expects Delay in U.S. Approval of..
      6/28/202319:00GLOBEAlvotech Provides Regulatory Update on Second Biologics..
      6/12/202307:00BWAlvotech and Teva Secure U.S. License Date for AVT04, a..
      6/12/202303:00GLOBEAlvotech and Teva Secure U.S. License Date for AVT04, a..
      5/31/202305:20GLOBEAlvotech to Participate in Jefferies Healthcare Conference
      5/24/202305:00GLOBEAlvotech and Advanz Pharma extend strategic partnership to..
      5/19/202305:00GLOBEAlvotech Reports Financial Results for First three Months of..
      5/17/202305:00GLOBEAlvotech to Participate in Morgan Stanley Annual..
      5/15/202305:00GLOBEAlvotech Issues Annual Equality Report Covering 2022
      5/10/202305:00GLOBEAlvotech enters into commercialization agreement with..
      5/04/202305:00GLOBEAlvotech Initiates Confirmatory Patient Study for AVT05, a..
      5/03/202309:00GLOBEAlvotech to Report First Quarter 2023 Financial Results and..

      Your Recent History

      NASDAQ
      ALVO
      Alvontech
      Delayed Upgrade Clock